The H116 trading update highlights net fee income 13% ahead driven by a strong performance from the group’s international markets. The UK accounts for just 19% of Arden’s forecast FY17 EBIT and, whilst this market has softened, the global bias to Technical and IT recruitment is providing earnings resilience. The US acquisition of Pharmaceutical Strategies last year looks particularly well timed given the relative strengthening of the US$ and the recent acquisition of Rishworth in
21 Jul 2016
Trading update; 14% FY16 EPS growth forecast intact
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Trading update; 14% FY16 EPS growth forecast intact
Empresaria Group plc (EMR:LON) | 36.5 0 0.0% | Mkt Cap: 18.2m
- Published:
21 Jul 2016 -
Author:
Ben Thefaut -
Pages:
4
The H116 trading update highlights net fee income 13% ahead driven by a strong performance from the group’s international markets. The UK accounts for just 19% of Arden’s forecast FY17 EBIT and, whilst this market has softened, the global bias to Technical and IT recruitment is providing earnings resilience. The US acquisition of Pharmaceutical Strategies last year looks particularly well timed given the relative strengthening of the US$ and the recent acquisition of Rishworth in